Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

NCT02979639 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)

Sponsor

GlaxoSmithKline